Marksans Pharma announced that he USFDA has issued an Establishment Inspection Report (EIR) for its manufacturing facility located at Verna, Goa and the inspection has now been successfully closed by the USFDA. USFDA has determined that the inspection classification of this facility is Voluntary Action Indicated (VAI).
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content